China Regulatory Express: 12 Months Exclusivity Proposed For First Generics
Plus Draft Guidelines for Gene Therapy
China’s National Medical Products Administration has released several key regulations and proposals designed to encourage first generics through a 12-month market exclusivity proposal and accelerate gene therapy development.
You may also be interested in...
Touting its coronavirus vaccines as a "global public good", China is quietly preparing for the first general approvals and launches, possibly within weeks, developers say. But who will be first in line to receive them? And at what cost? Distribution and pricing are just some of the unanswered questions.
China is set to grant priority reviews to major biologics from Roche, the first CAR-T therapy from Wuxi Juno, and breakthrough therapy designation to a pediatric respiratory antiviral from ArkBio.
China’s National Medical Products Administration has released key regulations and proposals designed to encourage first generics through a 12-month market exclusivity proposal.